By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Shin Nippon Biomedical Laboratories 



      Japan
Phone: Fax:


SEARCH JOBS








Company News
Transcept Pharmaceuticals, Inc. (TSPT) and Shin Nippon Biomedical Laboratories Announce Global Licensing Agreement for Advanced Acute Migraine Treatment 9/26/2013 10:56:14 AM
Shin Nippon Biomedical Laboratories Release: Novel Nasal Epinephrine Shows Comparable Absorption to EpiPen® in a Feasibility Study 9/10/2013 9:25:08 AM
Results of Shin Nippon Biomedical Laboratories First Phase I Clinical Study for Intranasal Zolmitriptan Formulation (Migraine Drug) 4/6/2012 10:05:34 AM
Shin Nippon Biomedical Laboratories Release: First Report on Results of US Phase 2 Clinical Study of Intranasal Granisetron 8/4/2009 1:51:25 PM
Shin Nippon Biomedical Laboratories Agrees Licensing Nasal Drug Delivery Technology To Tokai Pharmaceuticals 8/14/2006 1:24:55 PM
Shin Nippon Biomedical Laboratories And Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Successfully Complete Joint Research On Cynomolgus Monkey 6/26/2006 2:40:34 PM
Shin Nippon Biomedical Laboratories Obtains New Knowledge On Drug-Metabolizing Enzyme Cytochrome P450 5/10/2006 2:36:55 PM
Japanese Firm Plans To Invest $20M In City 10/19/2005 5:13:17 PM
Shin Nippon Biomedical Laboratories Develops Intranasal Morphine Preparation10/19/2005 5:12:05 PM
Shin Nippon Biomedical Laboratories And Tranzyme Pharma To Co-Develop New Animal Model Using Primates10/19/2005 5:10:58 PM
12
//-->